Mizuho Desk Comments on Replimune (REPL)
Tweet
Share
E-mailGet Alerts REPL Hot Sheet
Price: $5.41 +1.12%
Rating Summary:
6 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 15 | New: 11
Rating Summary:
6 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 15 | New: 11
Join SI Premium – FREE
Mizuho Desk Comments on Replimune (NASDAQ: REPL)
The analyst comments "REPL. Stock clobbered on CRL. This came up a few times last month at investor meetings on unfavorable risk/reward into the PDUFA. Playing out nicely this morning for those patient enough to stay the course on short side given the recent move higher into today’s catalyst."
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Replimune (REPL) Weakness Tied to FDA Briefing Documents, Shares -18%
- Evercore ISI on Meta Platforms Inc. (META): 'These were very solid results for Meta, fundamentally'
- Manganese X names new CFO, mourns passing of director
Create E-mail Alert Related Categories
Analyst Comments, Hot CommentsRelated Entities
Maynard Um, PDUFA, Mark Zuckerberg, ARK, MizuhoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
